Skip to main navigationSkip to main content
The University of Southampton
We're launching a new website soon and would love your feedback. See the new design

HRT associated with reduced COVID deaths

Published: 19 May 2022
COVID image

A new Southampton study indicates that receiving hormone replacement therapy (HRT) within six months of a recorded diagnosis of COVID-19 is associated with a reduction in mortality from the disease.

The study, published in Family Practice and led by Dr Christopher Wilcox, investigated the association between hormone replacement therapy or combined oral contraception use, and the likelihood 

They identified a group of 1,863,478 women from 465 general practices in England. There were 5451 COVID-19 cases within the cohort. Hormone replacement therapy was associated with a 78% reduction in all-cause mortality in COVID-19. of death in women with COVID-19.


Read more on the main University website.

Related Staff Member

Privacy Settings